JSM 2004 - Toronto

Keyword Search
Keyword=clinical trials

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
  301570  By:    2:45 PM 08/08/2004
Optimized Two-stage Adaptive Design

  301332  By:    2:50 PM 08/08/2004
Application of Statistical Sampling Principles to Clinical Trial Management

  301567  By:    3:35 PM 08/08/2004
The Growing Role of the Biostatistician in Safety Assessment of Clinical Trials for Regulatory Approval

  301514  By:    08/09/2004
Analyzing Actual and Percentage Change as an Endpoint with or without Baseline as a Covariate in Clinical Trials

  301402  By:    08/09/2004    ML03
ML03   Issues in Megatrials

  300668  By:    08/09/2004
A Bayesian Two-stage Phase II Design with Historical Controls

  300035  By:  Xihong Lin 10:35 AM 08/09/2004
Causal Inference in Hybrid Intervention Trials Involving Treatment Choice

  300398  By:    10:55 AM 08/09/2004
Statistical Cost-effectiveness Analysis: Incremental Net Benefit

  302230  By:    11:55 AM 08/09/2004
The Future for Statistical Analysis of Net-benefit in Cost-effectiveness Analysis

  300306  By:    2:45 PM 08/09/2004
Bayesian Innovations in Clinical Trial Design and Analysis

  301502  By:    2:50 PM 08/09/2004
Modeling LOCF Analysis of Continuous Endpoints in Clinical Trials

  300024  By:  Peter Thall 3:05 PM 08/09/2004
Hybrid Adaptive Designs for Clinical Trials

  300854  By:    9:35 AM 08/10/2004
Restructuring of Biostatistics at UAB

  302143  By:    12:05 PM 08/10/2004
Optimal Three-stage Study Design for Single-arm Phase II Clinical Trials

  300281  By:    2:55 PM 08/10/2004
Why Specify Best Practices? The Case for Anarchy

  301858  By:    3:25 PM 08/10/2004
Clinical Trial Designs for Dose-seeking, Non-MTD Trials with Biomarker Endpoints

  301812  By:    08/11/2004    WL03
WL03   Practical Issues in Sample Size Re-estimation in Clinical Trials - SOLD OUT

  300461  By:    9:05 AM 08/11/2004
Unbiased Estimation Following a Group Sequential Test for Distributions in the Exponential Family

  300945  By:    10:35 AM 08/11/2004
Toward a New Way of Thinking about Power and Sample Size

  301071  By:    11:15 AM 08/11/2004
Bayesian Screening Tool for Clinical Safety Data

  302152  By:    11:20 AM 08/11/2004
On the Adaptiveness of a Simple Bayesian Model for Treatment Assignments in Clinical Trials

  301587  By:  Guowen (Gordon) Sun 2:05 PM 08/11/2004
An Introduction to the Analysis and Interpretation of Radiographic Data from Rheumatoid Arthritis Clinical Trials

  301529  By:    2:20 PM 08/11/2004
Cox Regression Methods for Two-stage Randomization Designs

  301355  By:    8:35 AM 08/12/2004
Analysis of Clinical Trial Data When Treatments Favor Different Endpoints

  300643  By:  Daniel Heitjan 8:55 AM 08/12/2004
Analysis of Incomplete HRQoL Data in the REMATCH Trial

  300264  By:    9:05 AM 08/12/2004
Design and Analysis Issues in Pharmaco-genetics/-genomics Studies

  301248  By:    11:05 AM 08/12/2004
Analysis Strategies for Multiple-outcome Measures

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004